Innate Pharma S.A. (EPA:IPH)
2.010
-0.035 (-1.71%)
May 12, 2025, 5:35 PM CET
Innate Pharma Employees
Innate Pharma had 181 employees as of December 31, 2024. The number of employees increased by 2 or 1.12% compared to the previous year.
Employees
181
Change (1Y)
2
Growth (1Y)
1.12%
Revenue / Employee
€111,166
Profits / Employee
€273,320
Market Cap
185.24M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
EssilorLuxottica Société anonyme | 153,498 |
Sanofi | 82,878 |
Sartorius Stedim Biotech | 9,901 |
bioMérieux | 14,754 |
Eurofins Scientific SE | 62,696 |
Ipsen | 5,358 |
Virbac | 6,365 |
emeis Société anonyme | 83,494 |
Innate Pharma News
- 7 days ago - Innate Pharma announces conference call and webcast for Q1 2025 business update - Business Wire
- 12 days ago - Innate Pharma Files Its 2024 Universal Registration Document (Document d'enregistrement universel) and 2024 Annual Report on Form 20-F - Business Wire
- 13 days ago - Innate Pharma Highlights Preclinical Anti-Tumor Efficacy Data of Its Antibody Drug Conjugate IPH4502 at the AACR 2025 Annual Meeting - Business Wire
- 19 days ago - Innate Pharma Announces €15M Investment by Sanofi - Business Wire
- 20 days ago - Innate Pharma Regains Its Rights on CD123 Targeting ANKET® and Announces Sanofi's Intention to Make a Strategic Investment in the Company - Business Wire
- 27 days ago - Innate Pharma Proposes to Its Shareholders to Transform Its Corporate Governance Structure Into a Board of Directors and to Change Its Composition - Business Wire
- 27 days ago - Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 22, 2025 - Business Wire
- 5 weeks ago - Innate Pharma to Participate in the 2025 Stifel Virtual Targeted Oncology Forum - Business Wire